Efficacy of Pleuran (β-Glucan from Pleurotus ostreatus) in the Management of Herpes Simplex Virus Type 1 Infection

Table 1

Demographic characteristics of the study groups.

Parameter	Group		P
	Active	Placebo
Acute treatment phase	90 subjects
Patients (n)	49	41	n.s.
Age (years)	25.3 ± 2.3	17.4 ± 1.5	0.005
Males (n/%)	17 (34.7)	20 (48.8)	n.s.
Females (n/%)	32 (65.3)	21 (51.2)
Number of herpes exacerbations during 6 months before study (n)	2.7 ± 0.5	1.7 ± 0.3	n.s.
Number of herpes exacerbations during 12 months before study (n)	4.0 ± 0.5	3.2 ± 0.4	n.s.
Preventive phase	77 subjects
Patients (n)	39	38	n.s.
Age (years)	26.1 ± 2.5	17.6 ± 1.4	0.008
Males (n/%)	14 (35.9)	18 (47.4)	n.s.
Females (n/%)	25 (64.1)	20 (52.6)